Manulife (Manufacturers Life Insurance)’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,045
Closed -$324K 2590
2018
Q3
$324K Sell
2,045
-151
-7% -$22.8K ﹤0.01% 2508
2018
Q2
$307K Sell
2,196
-638
-23% -$87.6K ﹤0.01% 2763
2018
Q1
$377K Buy
2,834
+548
+24% +$74.8K ﹤0.01% 2533
2017
Q4
$285K Buy
2,286
+540
+31% +$66.7K ﹤0.01% 2743
2017
Q3
$216K Buy
1,746
+353
+25% +$41.8K ﹤0.01% 2917
2017
Q2
$159K Buy
1,393
+159
+13% +$17.1K ﹤0.01% 3187
2017
Q1
$130K Buy
1,234
+734
+147% +$73.6K ﹤0.01% 3069
2016
Q4
$45K Buy
500
+60
+14% +$5.62K ﹤0.01% 3442
2016
Q3
$44K Hold
440
﹤0.01% 3420
2016
Q2
$39K Buy
+440
New +$40.4K ﹤0.01% 3401

Other funds holding FBT

Manulife (Manufacturers Life Insurance)'s FBT Position: Q4 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2018, closing a stake of 2,045 shares — an estimated $324K sold.

Manulife (Manufacturers Life Insurance) first reported a position in FBT in Q2 2016 and held it in 10 quarters. The position peaked at $377K in Q1 2018. 194 funds tracked by Wall St. Rank hold FBT as of Q4 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 2,045 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2018, an estimated $324K.
  • Manulife (Manufacturers Life Insurance) first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2016 and held it in 10 quarters.
  • Manulife (Manufacturers Life Insurance)'s First Trust NYSE Arca Biotechnology Index Fund position peaked at $377K in Q1 2018.
  • 194 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2018, filed 14 Feb 2019.